These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12625993)

  • 1. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series.
    Carrey N; MacMaster FP; Sparkes SJ; Khan SC; Kusumakar V
    J Child Adolesc Psychopharmacol; 2002; 12(4):331-6. PubMed ID: 12625993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V; Bittsansky M; Ondrejka I; Dobrota D
    Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ; MacMaster FP; Gaudet L; Schmidt MH
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):11-7. PubMed ID: 17343550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.
    Isaksson J; Hogmark Å; Nilsson KW; Lindblad F
    Psychiatry Res; 2013 Oct; 209(3):740-1. PubMed ID: 23850434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
    Kratochvil CJ; Heiligenstein JH; Dittmann R; Spencer TJ; Biederman J; Wernicke J; Newcorn JH; Casat C; Milton D; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):776-84. PubMed ID: 12108801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS).
    Wiguna T; Guerrero AP; Wibisono S; Sastroasmoro S
    Clin Neuropharmacol; 2012; 35(2):81-5. PubMed ID: 22318191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL; Chia S; Shang CY; Gau SS
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
    Unal GA; Kenar AN; Herken H; Kiroglu Y
    Neurosci Lett; 2015 Sep; 604():188-92. PubMed ID: 26257254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
    Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
    Starr HL; Kemner J
    J Natl Med Assoc; 2005 Oct; 97(10 Suppl):11S-16S. PubMed ID: 16350601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
    Hammerness P; Biederman J; Petty C; Henin A; Moore CM
    CNS Neurosci Ther; 2012 Jan; 18(1):34-40. PubMed ID: 21143432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
    Ota T; Iida J; Nakanishi Y; Sawada S; Matsuura H; Yamamuro K; Ueda S; Uratani M; Kishimoto N; Negoro H; Kishimoto T
    Psychiatry Clin Neurosci; 2015 Mar; 69(3):161-70. PubMed ID: 25359429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis.
    Hazell PL; Kohn MR; Dickson R; Walton RJ; Granger RE; Wyk GW
    J Atten Disord; 2011 Nov; 15(8):674-83. PubMed ID: 20837981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatments of hyperactive child].
    Le Heuzey MF
    Arch Pediatr; 2004 Jan; 11(1):64-9. PubMed ID: 14700769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term pharmacotherapy by methylfenidate or atomoxetine DAT 1 10/10 ADHD children in correlation with results of the imaging methods.
    Pribilova N; Paclt I; Kollarova P; Kohoutova M; Dezortova M; Hajek M; Csemy L
    Neuro Endocrinol Lett; 2016 Sep; 37(4):289-294. PubMed ID: 27857045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.